Molecular mechanisms of glucocorticoid action in rheumatic autoimmune diseases (Q34310272)

1 August 2017

1 reference

title

Molecular mechanisms of glucocorticoid action in rheumatic autoimmune diseases (English)

1 reference

1 August 2017

Eggert M

1

1 reference

1 August 2017

Schulz M

series ordinal

2

1 reference

1 August 2017

Neeck G

series ordinal

3

1 reference

1 August 2017

publication date

1 June 2001

1 reference

The Journal of Steroid Biochemistry and Molecular Biology

1 August 2017

published in

1 reference

1 August 2017

volume

77

1 reference

1 August 2017

issue

4-5

1 reference

1 August 2017

page(s)

185-191

1 reference

Transcriptional cross-talk, the second mode of steroid hormone receptor action

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

Glucocorticoid-induced apoptosis in lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

Molecular genetic dissection of glucocorticoid receptor function in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

Steroid receptor interactions with heat shock protein and immunophilin chaperones

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

The role of DnaJ-like proteins in glucocorticoid receptor.hsp90 heterocomplex assembly by the reconstituted hsp90.p60.hsp70 foldosome complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

Coactivator and corepressor complexes in nuclear receptor function

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

Effects of glucocorticoids in rheumatoid arthritis. Diminished glucocorticoid receptors do not result in glucocorticoid resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

DNA binding of the glucocorticoid receptor is not essential for survival

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

Function and activation of NF-kappa B in the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

Involvement of nuclear factor kappa B in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

Transcriptional roles of CCAAT/enhancer binding protein-beta, nuclear factor-kappaB, and C-promoter binding factor 1 in interleukin (IL)-1beta-induced IL-6 synthesis by human rheumatoid fibroblast-like synoviocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

Nuclear factor kappaB/p50 activates an element in the distal matrix metalloproteinase 1 promoter in interleukin-1beta-stimulated synovial fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

Nuclear factor kappaB activity is essential for matrix metalloproteinase-1 and -3 upregulation in rabbit dermal fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

Defining therapeutic targets by using adenovirus: blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

Regulation of transcription by MAP kinase cascades

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

The DNA binding-independent function of the glucocorticoid receptor mediates repression of AP-1-dependent genes in skin

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

Leflunomide suppresses TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal protein kinase, and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

The mechanism of taurine chloramine inhibition of cytokine (interleukin-6, interleukin-8) production by rheumatoid arthritis fibroblast-like synoviocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

The Effect of Glucocorticoids on Joint Destruction in Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

Low dose prednisolone therapy (LDPT) retards radiographically detectable destruction in early rheumatoid arthritis--preliminary results of a multicenter, randomized, parallel, double blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

Effects of Newcastle disease virus administration to mice on the metabolism of cerebral biogenic amines, plasma corticosterone, and lymphocyte proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

In the mouse, the activation of the hypothalamic-pituitary-adrenal axis by a lipopolysaccharide (endotoxin) is mediated through interleukin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

Selective depletion of macrophages prevents pituitary-adrenal activation in response to subpyrogenic, but not to pyrogenic, doses of bacterial endotoxin in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

Significance of increased secretion of glucocorticoids in mice and rats injected with bacterial endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

Analysis of the immune-encodrine feedback loop in the avian system and its alteration in chickens with spontaneous autoimmune thyroiditis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

Distinct roles for the NF-kappaB1 (p50) and c-Rel transcription factors in inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2801%2900058-9

7 January 2021

10.1016/S0960-0760(01)00058-9

Identifiers

DOI

1 reference

1 August 2017

1 reference